Douglas K. Owens, MD, MS; Martin Black, MD
Disclaimer: Dr. Owens is supported by the Department of Veterans Affairs. Views expressed here are those of the authors and do not necessarily reflect those of the Department of Veterans Affairs.
Potential Financial Conflicts of Interest: Honoraria: M. Black (Gilead).
Requests for Single Reprints: Douglas K. Owens, MD, MS, VA Palo Alto Health Care System (111A), 3801 Miranda Avenue, Palo Alto, CA 94304; e-mail, email@example.com.
Current Author Addresses: Dr. Owens: VA Palo Alto Health Care System (111A), 3801 Miranda Avenue, Palo Alto, CA 94304.
Dr. Black: Temple University School of Medicine, Philadelphia, PA.
Douglas K. Owens, Martin Black. Assessing the Benefits and Costs of New Therapies for Hepatitis B Virus Infection. Ann Intern Med. 2005;142:863–864. doi: 10.7326/0003-4819-142-10-200505170-00013
Download citation file:
Published: Ann Intern Med. 2005;142(10):863-864.
Gastroenterology/Hepatology, Infectious Disease, Liver Disease, Viral Hepatitis.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use